Cohlhepp Ryan — SEC Form 4 filings
SEC reporting owner CIK 2034665. 16 Form 4 filings on record with FilingPulse; latest filed 2026-09-10.
Transaction summary — filings shown
Covers all 16 filings on record, filed 2025-10-08 to 2026-09-10. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 29 legs across 14 filings — 215,500 shares, $4,596,627 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 29.
- Largest priced transaction: sale of 22,833 shares @ $28.76 ($656,652) in Bicara Therapeutics Inc., filed 2026-07-10.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Bicara Therapeutics Inc. (BCAX) | President, COO & Interim CEO, Director | 16 | — | 29 legs · 215,500 sh · $4,596,627 | 29 |
Form 4 filings — Cohlhepp Ryan
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-10 | 4 | Bicara Therapeutics Inc. (BCAX) | Option exercise (M): 17,500 @ $3.79 · Sale (S): 14,058 @ $22.77 · Sale (S): 3,442 @ $23.43 · Option exercise (M): 17,500 (derivative) @ $0 | EDGAR |
| 2026-08-12 | 4 | Bicara Therapeutics Inc. (BCAX) | Option exercise (M): 18,750 @ $3.79 · Sale (S): 18,750 @ $27.98 · Option exercise (M): 18,750 (derivative) @ $0 | EDGAR |
| 2026-07-10 | 4 | Bicara Therapeutics Inc. (BCAX) | Option exercise (M): 18,750 @ $3.79 · Sale (S): 22,833 @ $28.76 · Sale (S): 4,306 @ $29.80 · Sale (S): 1,075 @ $30.35 · Sale (S): 536 @ $29 · Option exercise (M): 18,750 (derivative) @ $0 | EDGAR |
| 2026-05-18 | 4 | Bicara Therapeutics Inc. (BCAX) | Option exercise (M): 8,000 @ $3.79 · Sale (S): 8,000 @ $20.29 · Sale (S): 4,500 @ $20.29 · Option exercise (M): 8,000 (derivative) @ $0 | EDGAR |
| 2026-04-17 | 4 | Bicara Therapeutics Inc. (BCAX) | Option exercise (M): 8,000 @ $3.79 · Sale (S): 8,000 @ $23.01 · Sale (S): 4,500 @ $23.01 · Option exercise (M): 8,000 (derivative) @ $0 | EDGAR |
| 2026-03-17 | 4 | Bicara Therapeutics Inc. (BCAX) | Option exercise (M): 8,000 @ $3.79 · Sale (S): 8,000 @ $19.66 · Sale (S): 4,500 @ $19.66 · Option exercise (M): 8,000 (derivative) @ $0 | EDGAR |
| 2026-03-05 | 4 | Bicara Therapeutics Inc. (BCAX) | Option exercise (M): 12,892 @ $3.79 · Sale (S): 12,892 @ $18.16 · Sale (S): 4,500 @ $18.16 · Option exercise (M): 12,892 (derivative) @ $0 | EDGAR |
| 2026-02-27 | 4 | Bicara Therapeutics Inc. (BCAX) | Option exercise (M): 3,108 @ $3.79 · Sale (S): 3,108 @ $18.04 · Sale (S): 523 @ $18.04 · Option exercise (M): 3,108 (derivative) @ $0 | EDGAR |
| 2026-02-04 | 4 | Bicara Therapeutics Inc. (BCAX) | Grant/award (A): 300,000 (derivative) @ $0 | EDGAR |
| 2026-01-26 | 4 | Bicara Therapeutics Inc. (BCAX) | Sale (S): 3,828 @ $18.10 | EDGAR |
| 2026-01-20 | 4 | Bicara Therapeutics Inc. (BCAX) | Sale (S): 149 @ $18.02 | EDGAR |
| 2025-12-29 | 4 | Bicara Therapeutics Inc. (BCAX) | Option exercise (M): 25,000 @ $4.44 · Option exercise (M): 25,000 (derivative) @ $0 | EDGAR |
| 2025-12-16 | 4 | Bicara Therapeutics Inc. (BCAX) | Option exercise (M): 8,000 @ $3.79 · Sale (S): 8,000 @ $18.68 · Sale (S): 4,500 @ $18.68 · Option exercise (M): 8,000 (derivative) @ $0 | EDGAR |
| 2025-11-25 | 4 | Bicara Therapeutics Inc. (BCAX) | Option exercise (M): 8,000 @ $3.79 · Sale (S): 8,000 @ $18.05 · Sale (S): 4,500 @ $18.05 · Option exercise (M): 8,000 (derivative) @ $0 | EDGAR |
| 2025-10-16 | 4 | Bicara Therapeutics Inc. (BCAX) | Option exercise (M): 8,000 @ $3.79 · Sale (S): 8,000 @ $18.16 · Sale (S): 4,500 @ $18.16 · Option exercise (M): 8,000 (derivative) @ $0 | EDGAR |
| 2025-10-08 | 4 | Bicara Therapeutics Inc. (BCAX) | Option exercise (M): 24,000 @ $3.79 · Sale (S): 24,000 @ $18.06 · Sale (S): 15,600 @ $18.06 · Option exercise (M): 8,000 @ $3.79 · Sale (S): 8,000 @ $18.06 · Sale (S): 2,900 @ $18.06 · +2 more | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2034665 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →